Session » Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
-
Abstract Number: 1872
Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma
-
Abstract Number: 1873
Inter and Intrarater Reliability of the Modified Rodnan Skin Score in Early Diffuse Systemic Sclerosis
-
Abstract Number: 1874
Impact of Socioeconomic Status on Survival in Connective Tissue Disease Associated and Idiopathic Pulmonary Arterial Hypertension
-
Abstract Number: 1875
Deep Vein Thrombosis and Pulmonary Embolism in Systemic Sclerois
-
Abstract Number: 1876
Caveolin 1 Gene Variants May Effect Disease Progression in Systemic Sclerosis Related Interstitial Lung Disease
-
Abstract Number: 1877
Prevalence and Risk Factors for Left Ventricular Diastolic Dysfunction in Scleroderma
-
Abstract Number: 1878
Diagnostic Performance of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis: Results from a Brazilian Validation Cohort
-
Abstract Number: 1879
Immunosuppressive “Routine”� Treatment of SSc Patients with Limited Cutaneous Involvement and Interstitial Lung Disease
-
Abstract Number: 1880
Circulating Microparticle Populations May Differentiate Between Connective Tissue Diseases.
-
Abstract Number: 1881
Is the Presence of Esophageal Dilation a Poor Prognostic Factor in Dilated Interstitial Lung Disease Associated with Systemic Sclerosis?
-
Abstract Number: 1882
The Predictive Value of Pulmonary Function Tests to Diagnose Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis
-
Abstract Number: 1884
Sensitivity to Change of Nailfold Videocapillaroscopy and Relationship with Disease Progression
-
Abstract Number: 1885
Identification and Clinical Correlations of Rare Autoantibodies in Systemic Sclerosis and Poly/Dermatomyositis Patients
-
Abstract Number: 1886
Myocardial Fibrosis Detected By Magnetic Resonance Imaging Is a Predictor of Heart Failure in Systemic Sclerosis (SSc) Patients
-
Abstract Number: 1887
Deficiency in Micronutrients Is a Frequent Burden in Patients with Systemic Sclerosis
-
Abstract Number: 1888
There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach
-
Abstract Number: 1889
Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
-
Abstract Number: 1890
Subclinical Biventricular Systolic Function Is Impaired in Patients with Systemic Sclerosis with Real Time 3-D Echpcardiography: 1 Year Follow-up Study
-
Abstract Number: 1891
Parameters That Predict Worsening of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis
-
Abstract Number: 1892
Impact of Cardiac Magnetic Resonance Imaging with T1 Mapping and Multi-b Value Diffusion-Weighted Sequences in Systemic Sclerosis for the Assessment of Myocardial Microscopic Fibrosis and Perfusion
-
Abstract Number: 1893
Relationship Between Vitamin D Levels and Disease Activity in Patients with Systemic Sclerosis
-
Abstract Number: 1894
Calcium Channel Blockers Are More Effective in the Treatment of Primary Raynaud’s Phenomenon Compared to Secondary: A Meta-Analyis
-
Abstract Number: 1895
Correlation of Scleroderma Interstitial Lung Disease with Gastroesophageal Reflux
-
Abstract Number: 1896
Early Signs, Symptoms and Auto-Antibodies to Predict Diffuse Cutaneous or Limited Cutaneous Systemic Sclerosis at First Presentation
-
Abstract Number: 1897
Fragmented Qrs Patterns Do Not Correlate with the Degree of Lung and Skin Involvement in Patients with Systemic Sclerosis
-
Abstract Number: 1898
Are There Risk Factors for Calcinosis in Scleroderma?
-
Abstract Number: 1899
Aortic Stenosis Is Increased in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Compared to Other Forms of Pulmonary Arterial Hypertension
-
Abstract Number: 1900
Performance of the Detect Protocol for Pulmonary Arterial Detection in Systemic Sclerosis Patients in Clinical Practice
-
Abstract Number: 1901
Association of Serum Adipokines Adipsin, Adiponectin, and Leptin/Adiponectin Ratio with Systemic Sclerosis
-
Abstract Number: 1902
Systemic Sclerosis and Lung Cancer Risk: Data from the Canadian Scleroderma Research Group